Lymphocyte subpopulations analysis in peripheral blood in polymyalgia rheumatica/giant cell arteritis. 1993

P Macchioni, and L Boiardi, and C Salvarani, and F Rossi, and M Casadei-Maldini, and R Mancini, and E Beltrandi, and I Portioli
2 Divisione di Medicina Interna (Unità Reumatologica), USL N9, Reggio Emilia, Italy.

The phenotypic characteristics of peripheral blood lymphocytes were investigated in 22 patients suffering from active polymyalgia rheumatica/giant cell arteritis (PMR/GCA) prior to steroid treatment. We observed a significant reduction in the absolute number and the relative percentage of CD4-, CD8+ and CD3+, CD16+ and/or CD56+ cells compared to controls. Fifteen patients were investigated prospectively over a 6-month period of prednisone therapy. At the end of the study CD4-CD8+ cells had increased significantly compared to baselines, CD3+ CD16+ and/or CD56+ cells remained significantly lower when compared to controls. We did not observe any abnormalities in the absolute number and percentage of HLA-DR+ T lymphocytes, CD5+ B cells and NK cell phenotypes before or during steroid treatment. Our study confirms that there was significant increase in the absolute number of CD8+ T cells during steroid treatment in the PMR/GCA patients, but indicates the persistence of an immunological alteration despite the control of disease manifestations.

UI MeSH Term Description Entries
D007958 Leukocyte Count The number of WHITE BLOOD CELLS per unit volume in venous BLOOD. A differential leukocyte count measures the relative numbers of the different types of white cells. Blood Cell Count, White,Differential Leukocyte Count,Leukocyte Count, Differential,Leukocyte Number,White Blood Cell Count,Count, Differential Leukocyte,Count, Leukocyte,Counts, Differential Leukocyte,Counts, Leukocyte,Differential Leukocyte Counts,Leukocyte Counts,Leukocyte Counts, Differential,Leukocyte Numbers,Number, Leukocyte,Numbers, Leukocyte
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011111 Polymyalgia Rheumatica A syndrome in the elderly characterized by proximal joint and muscle pain, high erythrocyte sedimentation rate, and a self-limiting course. Pain is usually accompanied by evidence of an inflammatory reaction. Women are affected twice as commonly as men and Caucasians more frequently than other groups. The condition is frequently associated with GIANT CELL ARTERITIS and some theories pose the possibility that the two diseases arise from a single etiology or even that they are the same entity. Forestier-Certonciny Syndrome,Pseudopolyarthritis, Rhizomelic,Rheumatism, Peri-Extra-Articular,Forestier Certonciny Syndrome,Peri-Extra-Articular Rheumatism,Pseudopolyarthritides, Rhizomelic,Rheumatism, Peri Extra Articular,Rhizomelic Pseudopolyarthritides,Rhizomelic Pseudopolyarthritis,Syndrome, Forestier-Certonciny
D011241 Prednisone A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver. Dehydrocortisone,delta-Cortisone,Apo-Prednisone,Cortan,Cortancyl,Cutason,Dacortin,Decortin,Decortisyl,Deltasone,Encorton,Encortone,Enkortolon,Kortancyl,Liquid Pred,Meticorten,Orasone,Panafcort,Panasol,Predni Tablinen,Prednidib,Predniment,Prednison Acsis,Prednison Galen,Prednison Hexal,Pronisone,Rectodelt,Sone,Sterapred,Ultracorten,Winpred,Acsis, Prednison
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000369 Aged, 80 and over Persons 80 years of age and older. Oldest Old

Related Publications

P Macchioni, and L Boiardi, and C Salvarani, and F Rossi, and M Casadei-Maldini, and R Mancini, and E Beltrandi, and I Portioli
February 1994, British journal of rheumatology,
P Macchioni, and L Boiardi, and C Salvarani, and F Rossi, and M Casadei-Maldini, and R Mancini, and E Beltrandi, and I Portioli
January 1980, The Journal of rheumatology,
P Macchioni, and L Boiardi, and C Salvarani, and F Rossi, and M Casadei-Maldini, and R Mancini, and E Beltrandi, and I Portioli
January 1983, Clinical and experimental rheumatology,
P Macchioni, and L Boiardi, and C Salvarani, and F Rossi, and M Casadei-Maldini, and R Mancini, and E Beltrandi, and I Portioli
November 1997, Praxis,
P Macchioni, and L Boiardi, and C Salvarani, and F Rossi, and M Casadei-Maldini, and R Mancini, and E Beltrandi, and I Portioli
June 1997, The American journal of medicine,
P Macchioni, and L Boiardi, and C Salvarani, and F Rossi, and M Casadei-Maldini, and R Mancini, and E Beltrandi, and I Portioli
January 1977, Verhandlungen der Deutschen Gesellschaft fur Innere Medizin,
P Macchioni, and L Boiardi, and C Salvarani, and F Rossi, and M Casadei-Maldini, and R Mancini, and E Beltrandi, and I Portioli
August 1978, Journal of neurology,
P Macchioni, and L Boiardi, and C Salvarani, and F Rossi, and M Casadei-Maldini, and R Mancini, and E Beltrandi, and I Portioli
January 1971, JAMA,
P Macchioni, and L Boiardi, and C Salvarani, and F Rossi, and M Casadei-Maldini, and R Mancini, and E Beltrandi, and I Portioli
November 2006, American family physician,
P Macchioni, and L Boiardi, and C Salvarani, and F Rossi, and M Casadei-Maldini, and R Mancini, and E Beltrandi, and I Portioli
October 2014, The New England journal of medicine,
Copied contents to your clipboard!